Internal Quantification Standard for NGS Data Normalization

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Next-Generation Sequencing (NGS) technologies face challenges in clinical and diagnostic applications due to high intra-lab and inter-lab variation, limited ability to distinguish clinically relevant organisms from commensals, and lack of accurate absolute quantification methods, leading to variability in genetic variation analysis and pathogen detection.

Innovation Solution

A universal internal quantification standard is introduced that can be added to samples during preparation, allowing for simultaneous quantification of multiple targets and accounting for assay-specific and matrix-derived variances, enabling normalization of sequencing data and accurate determination of nucleic acid concentrations across all samples.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Quantity of substance

If NGS is used to detect both highly and minimally concentrated organisms, then the dynamic range is extended, but the ability to distinguish clinically relevant organisms from commensals is reduced

Engineering Contradiction:
Improvedynamic range of detectionVSAvoidability to distinguish clinically relevant organisms
Core Design Contradiction:
Quantity of substanceVSMeasurement precision

Solution Approach 1:

The patent introduces an internal quantification standard (IQS) as an intermediary substance that competes with target nucleic acids for sequencing reads. By adding a known quantity of IQS to each sample, the system can calculate the input quantity of target nucleic acids based on the ratio of target reads to IQS reads, enabling accurate quantification across a wide dynamic range while maintaining the ability to distinguish clinically relevant organisms from commensals.

Inventive Principle:
Principle #24Intermediary (Mediator)

2Productivity

If NGS library preparation and sequencing reaction preparation are performed, then sequencing data is generated, but intra-lab and inter-lab variation increases

Engineering Contradiction:
Improvesequencing data generationVSAvoidintra-lab and inter-lab variation
Core Design Contradiction:
ProductivityVSReliability

Solution Approach 1:

The patent implements a feedback mechanism by including an internal quantification standard throughout the entire library preparation and sequencing process. The IQS serves as a control that allows calculation of process efficiency and normalization of sequencing data. By comparing the observed number of IQS reads to the expected number based on input quantity, the system can identify and correct for variations in library preparation and sequencing efficiency across different labs and runs.

Inventive Principle:
Principle #23Feedback

Solution Approach 2:

The internal quantification standard enables the sequencing assay to self-correct for technical variations. Each sample contains its own IQS that undergoes the same preparation steps, allowing the system to automatically normalize data and compensate for lab-specific protocols and reagent batches without requiring external calibration.

Inventive Principle:
Principle #25Self-service

3Measurement precision

If relative quantification is performed using serial dilutions, then the relationship between read numbers and target abundance is established, but absolute quantification capability is lost

Engineering Contradiction:
Improverelative quantification accuracyVSAvoidabsolute quantification capability
Core Design Contradiction:
Measurement precisionVSQuantity of substance

Solution Approach 1:

The patent transforms the quantification approach by changing the parameter of reference. Instead of using relative references (serial dilutions of unknown samples), the system introduces an absolute reference (IQS with known input quantity). This parameter change enables the calculation of absolute input quantities of target nucleic acids using the formula: input quantity = (number of target reads / number of IQS reads) × input quantity of IQS, while maintaining the linear relationship observed in relative quantification.

Inventive Principle:
Principle #35Parameter changes

Data Source

PatentUS20210180112A1Methods for normalization and quantification of sequencing data
Publication Date: 2021.06.17 BIOFIRE DIAGNOSTICS LLC
  • US20210180112A1 patent drawing
  • US20210180112A1 patent drawing
  • US20210180112A1 patent drawing

AI summary

Methods and kits for normalization and quantification of sequencing data.